Two Vaccine Targets on Virus May Be Better Than One
An experimental vaccine developed by GeoVax Labs succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study.
Reuters Health Information
source https://www.medscape.com/viewarticle/970179?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/970179?src=rss
Comments
Post a Comment